These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3611947)

  • 21. Lactulose (cephulac) in portosystemic encephalopathy.
    Kosman ME
    JAMA; 1976 Nov; 236(21):2444-5. PubMed ID: 989871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Portal systemic encephalopathy--should lactulose and neomycin be used together.
    Martin AJ
    Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185
    [No Abstract]   [Full Text] [Related]  

  • 23. Lactulose for hepatic encephalopathy.
    Med Lett Drugs Ther; 1976 Jan; 18(1):3-4. PubMed ID: 1105127
    [No Abstract]   [Full Text] [Related]  

  • 24. The degradation of amino acids, proteins, and blood to short-chain fatty acids in colon is prevented by lactulose.
    Mortensen PB; Holtug K; Bonnén H; Clausen MR
    Gastroenterology; 1990 Feb; 98(2):353-60. PubMed ID: 2295390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of portal-systemic encephalopathy: the practical and the promising.
    Weber FL
    Gastroenterology; 1981 Jul; 81(1):174-7. PubMed ID: 7239116
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of lactulose on the faecal flora of patients with hepatic encephalopathy.
    Vince A; Zeegen R; Drinkwater JE; O'Grady F; Dawson AM
    J Med Microbiol; 1974 May; 7(2):163-8. PubMed ID: 4600290
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy].
    Sala Felis T; Berenguer J; Barrios JM; Gómez J
    Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021
    [No Abstract]   [Full Text] [Related]  

  • 28. Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora.
    Weber FL
    Dig Dis; 1996; 14 Suppl 1():53-63. PubMed ID: 8872452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects.
    Weber FL; Fresard KM; Lally BR
    Gastroenterology; 1982 Feb; 82(2):213-7. PubMed ID: 7054022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
    Bircher J; Haemmerli UP; Scollo-Lavizzari G; Hoffmann K
    Am J Med; 1971 Aug; 51(2):148-59. PubMed ID: 5095524
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy.
    Lam KC; Tall AR; Goldstein GB; Mistilis SP
    Scand J Gastroenterol; 1973; 8(6):465-72. PubMed ID: 4589374
    [No Abstract]   [Full Text] [Related]  

  • 32. The mechanism of action of lactulose in portal systemic encephalopathy: colonic bacterial urease activity and bacterial flora in rats.
    Bircher J; Haemmerli UP; Müller-Duysing W; Bally G; Haemmerli G; Hoffmann K
    Rev Eur Etud Clin Biol; 1970 Dec; 15(10):1096-100. PubMed ID: 5517889
    [No Abstract]   [Full Text] [Related]  

  • 33. Lactulose and ammonia.
    Herrmann R; Weber FL
    Lancet; 1987 Dec; 2(8571):1333. PubMed ID: 2890930
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy.
    Bongaerts G; Severijnen R; Timmerman H
    Med Hypotheses; 2005; 64(1):64-8. PubMed ID: 15533613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of hepatic cirrhosis and hepatic coma with drugs having the capacity of lowering the blood ammonia levels].
    Müting D
    Clin Ter; 1967 Aug; 42(4):289-97. PubMed ID: 5608820
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lactulose].
    Prat F; Lambert R
    Gastroenterol Clin Biol; 1990; 14(6-7):567-75. PubMed ID: 2397865
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative effects of lactulose and magnesium sulfate on urea metabolism and nitrogen excretion in cirrhotic subjects.
    Weber FL; Fresard KM
    Gastroenterology; 1981 May; 80(5 pt 1):994-8. PubMed ID: 7202981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic encephalopathy.
    Fraser CL; Arieff AI
    N Engl J Med; 1985 Oct; 313(14):865-73. PubMed ID: 2993889
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of lactitol (NS-4) on the increase in blood and brain ammonia concentration and on coma in newly developed rat models of hepatic coma].
    Watanabe M; Ozaki T; Hirata Y; Yoshikuni Y; Kimura K
    Nihon Yakurigaku Zasshi; 1995 Feb; 105(2):97-109. PubMed ID: 7737597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of three antibacterial drugs in lowering blood & stool ammonia production in hepatic encephalopathy.
    Alexander T; Thomas K; Cherian AM; Kanakasabapathy
    Indian J Med Res; 1992 Oct; 96():292-6. PubMed ID: 1459672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.